From infant formula and health food clampdowns in China to food contamination and supplements controversy in New Zealand, read the latest regulatory news in our monthly review.
China will tighten its inspection of infant formula products that are pending registration approval by conducting more sample testing and on-site inspection.
In our latest Nutrition Asia video series, we find out what parents in APAC want, what new infant formula innovations to expect this year, and how industry can better provide for children’s nutritional needs.
The UAE Cabinet has implemented a blanket ban on the advertising of infant formula and other infant nutrition products, including follow-up formula and complementary foods.
Nestlé is once more the subject of complaints in India, most recently being accused again of attempting to influence paediatricians to promote its infant nutrition products to parents.
Nestlé's progress into China's A2 milk market and continual criticism by breastfeeding advocates in India feature in our top trending stories on social media this month, alongside South Korean cancer research, food fortification in India and...
From revamped regulations in New Zealand and India to controversy surrounding infant formula brands in APAC and a supplement firm in China, this month's regulatory review covers the latest news on ingredient, advertising and manufacturing laws in...
Out top 10 most read stories on regulation in the food and supplement industry feature China and India heavily, with cross-border e-commerce (CBEC) and infant formula rules in China a constant topic of interest, alongside stricter laws surrounding ingredients...
A JD-COFCO joint research centre has published a white paper which sheds light on the eight consumption and innovation trends dominating China's infant nutrition market.
The Breastfeeding Promotion Network of India (BPNI) has called for government action to restrict what it claims are attempts by infant nutrition companies to influence paediatricians to promote formula to mothers.
BioCeuticals' heavy investment in medical cannabis research, DSM China's sustainability efforts, and Sattvaponics' agricultural innovations feature alongside news on dietary supplement and infant formula contaminant in our five most read...
Read about Swisse's stellar performance at this year's Singles' Day sales, China's cross-border e-commerce (CBEC) regulations, Biostime's entry into Australia's infant formula market, and Aland's precision nutrition...
The prevalence of Bacillus cereus in infant and follow-up formula in China may warrant further research so criteria can be developed for risk assessment and quality control, say Chinese researchers.
China's Health & Happiness (H&H) Group has announced its entry into the Australian infant formula market with Biostime, which has already secured distribution agreements with major pharmacy chains like Chemist Warehouse.
Singles' Day, the world's largest annual shopping event, once again turned out to be a roaring success for Australian supplement firms selling to China.
It will soon be mandatory for couples registering for marriage in the Philippines to attend seminars on breastfeeding and infant nutrition before they can obtain their licences.
In our latest overview of market trends in APAC, China's online dairy sales have declined, while Australia's daigou sales for infant formula are soaring — much to the chagrin of local parents. Elsewhere, we look at new products in the beauty-from-within...
New Zealand's Commerce Commission has granted the Infant Nutrition Council (INC) authorisation to extend advertising and marketing restrictions to include infant formula products for children up to one year of age.
In our latest review of the major brand developments in the supplement and health food space, we look at Swisse's financials, Australia's infant formula shortage, and more.
Brands must share the responsibility for shortages of infant formula in some Australian stores, instead of heaping the blame on daigou shoppers, says Australia-China Daigou Association (ACDA) president Dr Mathew McDougall.
Nestlé is launching a A2 beta-casein protein infant formula product in Australia and New Zealand within the next two months, competing directly with first-mover a2 Milk.
Kiwi infant formula firm New Zealand New Milk is keen on increasing its market share in China, with new product development and the use of trusted retail platforms supporting its goal.
The Punjab Food Authority (PFA) has said it has restarted its action plan against infant formula firms that violate local regulations, ahead of the date previously communicated to industry representatives.
A forward-thinking approach to infant formula is required to properly benefit both industry and consumers in Asia-Pacific's diverse markets, and must be supported by extensive research and strong co-operation with regulators.
The world’s biggest dairy co-operative will review its stake in Chinese formula milk company Beingmate after unveiling the first ever annual loss in its 17-year history.
Health and Happiness (H&H) achieved a revenue of RMB4573.6m (about US$669m) in the first half of 2018, which is 28.8% higher than the same period last year.
Australian Dairy Farms Group Limited is acquiring Flahey's Nutritionals Pty Ltd, owners of Flahey's Future, a certified-organic formula containing vitamins, minerals, protein, carbohydrates, fats and prebiotic fiber.
Japan’s Ministry of Health, Labour and Welfare has revised an ordinance to permit the production and sale of liquid infant formula, leading some of the country’s biggest players to express an interest in entering the market.
Singapore’s Agri-Food & Veterinary Authority (AVA) has recalled a batch of Dumex Mamil Gold Infant Milk Formula - Step 1 (850g) after detecting cronobacter sakazakii bacteria in samples.
Australian organic infant formula manufacturer Bubs has announced a massive rise of over 500% in sales, thanks largely to the growth in export sales to China.
Australian firm Freedom Foods is targeting China and parts of South East Asia with its reformulated and repackaged infant formula range, after first entering the Singapore market last year.
Australian firm Nuchev is banking on its signature goat milk formula, Oli6, to develop products for both young children and seniors, spurred by a new study that pointed to the formula's health benefits.
UK firm Kendal Nutricare has signed a US$118m five-year contract deal with import / export company Orient International Holding Shanghai Foreign Trading Co. to distribute its organic infant formula in China.
Accusations levelled at Nestlé claim the Swiss corporate giants mislead consumers with nutritional claims about its infant formula products, flouting ethical marketing codes in the process.
China’s new infant formula laws have finally come into force, 18 months after the proposals were unveiled sparking regulatory uncertainty, market volatility and a frantic dash to meet the more stringent regulatory requirements.
Victoria-based manufacturer ViPlus Dairy claims to be the first Australian producer of locally made infant formula to be approved by the China Food and Drug Administration (CFDA).
UNICEF (United Nations Children’s Fund) Pakistan's nutrition chief Melanie Galvin has compared infant formula manufacturers to the tobacco industry, saying they have been "using similar tactics here after regulations were tightened against them...
Australian supplement firm Blackmores has entered Singapore's increasingly competitive infant formula market, albeit with a more cautious approach in light of recently enforced government regulations.
The demand for goat milk infant formula in soaring in Asia, according to Nuchev CEO Ben Dingle, who is targeting South East Asia market entry on the back of his company's success in China.
Parents in Hong Kong and China are the world's biggest spenders when it comes to infant formula, but consumer oragnisations have accused global manufacturers of 'exploiting parents concerns' around safety to charge premium prices.
Danone’s third quarter sales in 2017 grew by 4.7% to roughly $7.5bn, driven by its booming specialized nutrition business in China, which increased 17.8% in reported sales compared to the previous quarter.
Chinese authorities may have introduced more stringent infant formula rules, but New Zealand exports are continuing to soar, with Australia and New Zealand Banking Group (ANZ) economists forecasting they will soon top NZ$1bn for the first time.
The Punjab Food Authority (PFA) has issued a blanket ban on marketing and free sampling of infant formula in hospitals in Pakistan, following a meeting with Formula Milk Association office bearers on 26 September.
Digestive health and protein content are the top two priorities for infant formula manufacturers in APAC, leading to a surge in interest in prebiotics, probiotics and oligosaccharides.